Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Loss-of-function mutations in parkin are the predominant cause of familial Parkinson's disease. We previously reported that parkin-/- mice exhibit nigrostriatal deficits in the absence of nigral degeneration. Parkin has been shown to function as an E3 ubiquitin ligase. Loss of parkin function, therefore, has been hypothesized to cause nigral degeneration via an aberrant accumulation of its substrates. Here we employed a proteomic approach to determine whether loss of parkin function results in alterations in abundance and/or modification of proteins in the ventral midbrain of parkin-/- mice. Two-dimensional gel electrophoresis followed by mass spectrometry revealed decreased abundance of a number of proteins involved in mitochondrial function or oxidative stress. Consistent with reductions in several subunits of complexes I and IV, functional assays showed reductions in respiratory capacity of striatal mitochondria isolated from parkin-/- mice. Electron microscopic analysis revealed no gross morphological abnormalities in striatal mitochondria of parkin-/- mice. In addition, parkin-/- mice showed a delayed rate of weight gain, suggesting broader metabolic abnormalities. Accompanying these deficits in mitochondrial function, parkin-/- mice also exhibited decreased levels of proteins involved in protection from oxidative stress. Consistent with these findings, parkin-/- mice showed decreased serum antioxidant capacity and increased protein and lipid peroxidation. The combination of proteomic, genetic, and physiological analyses reveal an essential role for parkin in the regulation of mitochondrial function and provide the first direct evidence of mitochondrial dysfunction and oxidative damage in the absence of nigral degeneration in a genetic mouse model of Parkinson's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, mitophagy deficiency favored by ablation of Prkn (Palacino et al, 2004; Pickrell et al, 2015) or Pink1 (Gautier et al, 2008) sensitizes mice to oxidative stress, while worsening neural damage when combined with mitochondrial dysfunction (mitochondrial DNA [mtDNA] mutator‐prkn/parkin‐KO mice) (Pickrell et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Palacino et al, 2004
In the citing paper
“Both Pink1 and Parkin knockout mice exhibit increased ROS levels and mitochondrial dysfunction (43, 44), and persistent increased ROS is one of the important factors in accelerating cellular senescence (42, 45).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [43]
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Research works printed but not linked: 5
- Jenner, 1996, Neurology, 47, 5161
- Koller, 1986, Neurology, 36
- Darios, 2003, Hum. Mol. Genet., 12, 517, 10.1093/hmg/ddg044 · doi:10.1093/hmg/ddg044 · Paper page
- Klose, 1999, Methods Mol. Biol., 112, 67
- Dubin, 1989, Mol. Cell. Biol., 9, 1083
Cited by
Items 701–800 of 1,000
Stauch, K. L., Totusek, S., Trease, A. J., Estrella, L. D., Emanuel, K. M., Fangmeier, A., & Fox, H. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-38484-0 · Cited by 16
Martinez, A., Ramírez, J., Osinalde, N., Arizmendi, J. M., & Mayor, U. (2018) · BioMed Research International · doi:10.1155/2018/3180413 · Cited by 16
Spagnoli, C., Fusco, C., & Pisani, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043796 · Cited by 16
Aging, Parkinson’s Disease, and Models: What Are the Challenges?
Bellantuono, I., Mortiboys, H., Rocha, E. M., Chamoli, M., Chinta, S. J., Andersen, J. K., Wallis, R., Bézard, E., Goldberg, M., Greenamyre, T., et al. (2023) · doi:10.59368/agingbio.20230010 · Cited by 16
Self-citationStrategies to rescue mitochondria in Parkinson’s disease: The significance of mitochondrial transfer
Liang, J., Su, Z., Su, G., Rasheed, M., Tang, S., Sunniya, H., Maazouzi, M., Cui, Y., Wang, J., Wang, X., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102856 · Cited by 16
Zhu, Y., Aredo, B., Chen, B., Zhao, C. X., He, Y.-G., & Ufret-Vincenty, R. L. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27212 · Cited by 16
Axon-Specific Mitochondrial Pathology in SPG11 Alpha Motor Neurons
Güner, F., Pozner, T., Krach, F., Prots, I., Loskarn, S., Schlötzer-Schrehardt, U. M., Winkler, J., Winner, B., & Regensburger, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.680572 · Cited by 16
A Systematic Proteomic Study of Irradiated DNA Repair Deficient Nbn-Mice
Melchers, A., Stöckl, L., Radszewski, J., Anders, M., Krenzlin, H., Kalischke, C., Scholz, R., Jordan, A., Nebrich, G., Klose, J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005423 · Cited by 16
Self-citationParkin coregulates glutathione metabolism in adult mammalian brain
Kodsi, D. N. E., Tokarew, J. M., Sengupta, R., Lengacher, N. A., Chatterji, A., Nguyen, A., Boston, H., Jiang, Q., Palmberg, C., Pileggi, C. A., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01488-4 · Cited by 15
Can parkin be a target for future treatment of Parkinson's disease?
Kubo, S., Hatano, T., Takanashi, M., & Hattori, N. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.827173 · Cited by 15
Signorile, A., Ferretta, A., Pacelli, C., Capitanio, N., Tanzarella, P., Matrella, M. L., Valletti, A., Rasmo, D. D., & Cocco, T. (2021) · Biomolecules · doi:10.3390/biom11101511 · Cited by 15
Is there a pathogenic role for mitochondria in Parkinson's disease?
Vives-Bauzá, C., de Vries, R. L. A., Tocilescu, M. A., & Przedborski, S. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70823-5 · Cited by 15
RESP18 is Involved in the Cytotoxicity of Dopaminergic Neurotoxins in MN9D Cells
Huang, Y., Xu, J., Liang, M., Hong, X., Suo, H., Liu, J., Yu, M., & Huang, F. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9375-6 · Cited by 15
Parkin deficiency exacerbates fasting-induced skeletal muscle wasting in mice
Peker, N., Sharma, M., & Kambadur, R. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00419-3 · Cited by 14
Khan, S. H., Zhao, D., Shah, S. Z. A., Hassan, M. F., Zhu, T., Song, Z., Zhou, X., & Yang, L. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0407-7 · Cited by 14
Lizama, B. N., Palubinsky, A. M., & McLaughlin, B. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.013 · Cited by 14
Ding, Y., Aredo, B., Zhong, X., Zhao, C. X., & Ufret-Vincenty, R. L. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.03.009 · Cited by 14
Kim, J. J., Daadi, E. W., Oh, T. T., Daadi, E. S., & Daadi, M. M. (2022) · Genes · doi:10.3390/genes13111937 · Cited by 14
iPS models of Parkin and PINK1
Raković, A., Seibler, P., & Klein, C. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150010 · Cited by 14
Unravelling the role of defective genes
Cookson, M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83003-1 · Cited by 14
De novo tetrahydrobiopterin biosynthesis is impaired in the inflammed striatum of parkin(−/−) mice
Martins, R. D. P., Glaser, V., Aguiar, A. S., Ferreira, P. M. D. P., Ghisoni, K., Scheffer, D. D. L., Lanfumey, L., Raisman‐Vozari, R., Corti, O., Paul, A. L. D., et al. (2018) · Cell Biology International · doi:10.1002/cbin.10969 · Cited by 14
Identification of a novel thymidylate kinase activity
Frisk, J. H., Eriksson, S., Pejler, G., & Wang, L. (2020) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2020.1755043 · Cited by 14
O'Connor, J. L., Fountos, D. M., Firouzan, B., Azizi, F., Ghasemi, R., & Kashfi, K. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00710 · Cited by 13
Replicated association between genetic variation in the PARK2 gene and blood pressure
Jin, H., Hong, K., Kim, B. Y., Kim, J., Yoo, Y. H., Oh, B., & Jeong, S. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.05.026 · Cited by 13
Animal Models for the Study of Human Neurodegenerative Diseases
Colpo, G. D., Ribeiro, F. M., Rocha, N. P., & Teixeira, A. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00042-5 · Cited by 14
The Role of Neuroinflammation in Parkinson's Disease
Chen, X., & Tansey, M. G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384913-7.00018-6 · Cited by 13
Animal Models of Autosomal Recessive Parkinsonism
Bastioli, G., Regoni, M., Cazzaniga, F. A., Luca, C. M. G. D., Bistaffa, E., Zanetti, L., Moda, F., Valtorta, F., & Sassone, J. (2021) · Biomedicines · doi:10.3390/biomedicines9070812 · Cited by 13
Autosomal Recessive Mutations in the Development of Parkinson‘s Disease
Lopez, G. J., & Sidransky, E. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.96 · Cited by 13
Gene therapy for Parkinson’s disease
Mochizuki, H. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.8.957 · Cited by 12
From Obesity to Mitochondrial Dysfunction in Peripheral Tissues and in the Central Nervous System
Marino, F., Petrella, L., Cimmino, F., Pizzella, A., Monda, A., Allocca, S., Rotondo, R., D’Angelo, M., Musco, N., Iommelli, P., et al. (2025) · Biomolecules · doi:10.3390/biom15050638 · Cited by 12
Analysis of organelles within the nervous system: impact on brain and organelle functions
Tribl, F., Meyer, H. E., & Marcus, K. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.2.333 · Cited by 12
Mitochondrial Membranes of Human SH-SY5Y Neuroblastoma Cells Express Serotonin 5-HT7 Receptor
Tempio, A., Niso, M., Laera, L., Trisolini, L., Favia, M., Ciranna, L., Marzulli, D., Petrosillo, G., Pierri, C. L., Lacivita, E., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249629 · Cited by 12
Drosophila Models of Parkinson's Disease☆
Whitworth, A. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.00554-x · Cited by 12
Parkin regulates translesion DNA synthesis in response to UV radiation
Zhu, X., Ma, X., Tu, Y., Huang, M., Liu, H., Wang, F., Gong, J., Wang, J., Li, X., Chen, Q., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16855 · Cited by 12
Fonseca-Fonseca, L. A., Núñez-Figueredo, Y., Ramírez-Sánchez, J., Guerra, M. W., Ochoa, E., Verdecia-Reyes, Y., Delgado, R., Menezes-Filho, N. J., Costa, T. C. S., de Santana, W. A., et al. (2018) · Neurotoxicity Research · doi:10.1007/s12640-017-9851-5 · Cited by 11
Promising molecular targets for pharmacological therapy of neurodegenerative pathologies
Неганова, М. Е., Aleksandrova, Y. R., Nebogatikov, V. O., Klochkov, S. G., & Ustyugov, A. A. (2020) · Acta Naturae · doi:10.32607/actanaturae.10925 · Cited by 11
Neuroinflammation as a Potential Mechanism Underlying Parkinsons Disease
Cebrián, C., & Sulzer, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00008-0 · Cited by 11
Gunn, T. M., Silvius, D., Lester, A., & Gibbs, B. (2019) · Mammalian Genome · doi:10.1007/s00335-019-09802-7 · Cited by 11
Lu, X. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)89002-8 · Cited by 11
Identification and Molecular Characterization of Parkin in Clonorchis sinensis
Bai, X., Kim, T., Lee, J.-Y., Dai, F., & Hong, S. (2015) · Korean Journal of Parasitology · doi:10.3347/kjp.2015.53.1.65 · Cited by 11
Naseem, A., Bhat, Z. I., Ponnusamy, K., Kumar, B., Gandhi, G., & Rizvi, M. M. A. (2017) · Tumor Biology · doi:10.1177/1010428317703635 · Cited by 11
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
Cardoso, S., Santos, R. X., Correia, S. C., Carvalho, C., Zhu, X., Lee, H., Casadesús, G., Smith, M. A., Perry, G. L., & Moreira, P. I. (2009) · Pharmaceuticals · doi:10.3390/ph2030250 · Cited by 10
The proteomic approach in Parkinson's disease
Fasano, M., Bergamasco, B., & Lopiano, L. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200700264 · Cited by 10
Mitochondrial morphology and synaptic structure altered in the retina of parkin-deficient mice
Hu, Z.-X., Pu, J., Zheng, R., Yan, Y.-Q., Liu, K.-Y., Liu, Y., Zheng, R., Chen, Y., Lin, Z., Xue, N., et al. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136888 · Cited by 10
Genetic causes of Parkinson’s disease: extending the pathway
Rieß, O., Krüger, R., Hochstrasser, H., Soehn, A. S., Nuber, S., Franck, T., & Berg, D. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_29 · Cited by 10
Parkinson’s Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature
Das, B. B., Dash, S. P., Mohanty, S., & Patel, P. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_4 · Cited by 10
Of Parkin and Parkinson's: light and dark sides of a multifaceted E3 ubiquitin–protein ligase
Corti, O., & Brice, A. (2007) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2007.11.002 · Cited by 10
Mitochondria in the etiology of Parkinson's disease
Schapira, A. H. V. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83022-3 · Cited by 10
Frisk, J. H., Vanoevelen, J. M., Bierau, J., Pejler, G., Eriksson, S., & Wang, L. (2021) · ACS Omega · doi:10.1021/acsomega.1c05288 · Cited by 10
Physiology versus pathology in Parkinson's disease
Nakamura, K., & Edwards, R. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704254104 · Cited by 10
A novel role for parkin in trauma-induced central nervous system secondary injury
Mukhida, K., Kobayashi, N. R., & Méndez, I. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.12.020 · Cited by 10
Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s disease
Hollville, É., Joers, V. L., Nakamura, A., Swahari, V., Tansey, M. G., Moy, S. S., & Deshmukh, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-73854-y · Cited by 10
Gauvreau, N. L., Bragg, L. M., Dhiyebi, H. A., Servos, M. R., & Craig, P. M. (2022) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2022.109381 · Cited by 10
Chen, Y.-G., Yue, H., Zhang, Z.-Z., Yuan, F.-H., Bi, H., Yuan, K., Weng, S., He, J., & Chen, Y.-H. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.10.019 · Cited by 10
Mitochondria and Parkinson's Disease
Simon, D. K., Chu, C. T., & Swerdlow, R. H. (2011) · Parkinson s Disease · doi:10.4061/2011/261791 · Cited by 9
Pathogenic insights to Parkin-linked model mice
Sato, S., Noda, S., & Hattori, N. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.03.014 · Cited by 9
Seppet, E. K., Gizatullina, Z. Z., Trumbeckaitė, S., Zierz, S., Striggow, F., & Gellerich, F. N. (2007) · Wiley eBooks · doi:10.1002/9783527621095.ch15 · Cited by 9
Parkinson's disease and microRNAs - Lessons from model organisms and human studies
Evans, B., Furlong, H. A., & de Lencastre, A. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111585 · Cited by 9
Proteome alteration of U251 human astrocytoma cell after inhibiting retinoic acid synthesis
Zhang, M., Wan, C., Ji, B., Zhang, Z., Zhu, H., Tian, N., La, Y., Huang, K., Jiang, L., He, G., et al. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9978-z · Cited by 9
Chapter 8 α-Synuclein and Synucleinopathies
Schlossmacher, M. G. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70059-0 · Cited by 9
Yun, H. K., Park, J., Chae, U., Lee, H., Huh, J., Lee, S., Bae, Y. C., & Lee, D. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577044 · Cited by 9
Aresta, A. M., Vietro, N. D., Cotugno, P., Pierri, C. L., Trisolini, L., & Zambonin, C. G. (2024) · Antioxidants · doi:10.3390/antiox13030307 · Cited by 9
Yadav, R. (2013) · Cell & Developmental Biology · doi:10.4172/2168-9296.1000e122 · Cited by 9
Frisk, J. H., Örn, S., Pejler, G., Eriksson, S., & Wang, L. (2022) · BMC Neuroscience · doi:10.1186/s12868-022-00704-0 · Cited by 9
Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease
Lim, D., Matute, C., Cavaliere, F., & Verkhratsky, A. (2025) · Handbook of Clinical Neurology · doi:10.1016/b978-0-443-19102-2.00012-0 · Cited by 8
Kikkert, M., Hassink, G. C., & Wiertz, E. J. H. J. (2006) · Springer eBooks · doi:10.1007/3-540-28007-3_4 · Cited by 8
Musthafa, T., Nizami, S. K., Mishra, A., Hasan, G., & Gopurappilly, R. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70059 · Cited by 8
Siciliano, R. A., Mazzeo, M. F., Ferretta, A., Pacelli, C., Rosato, A., Papa, F., Scacco, S., Papa, S., Cocco, T., & Lippolis, R. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.154 · Cited by 8
Beneficial role of capsaicin through modulation of mitochondrial functions in MPTP-injected mice
Tyagi, S., & Thakur, A. K. (2024) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-024-01560-7 · Cited by 8
Mitochondrial dysfunction, iron accumulation, and ferroptosis in Parkinson’s disease
Teferi, N., Challa, M., Woodiwiss, T. R., Allen, B. G., & Petronek, M. S. (2023) · Redox Experimental Medicine · doi:10.1530/rem-23-0004 · Cited by 8
Redox Homeostasis in Well-differentiated Primary Human Nasal Epithelial Cells
Yamamoto, A., Sly, P. D., Henningham, A., Begum, N., Yeo, A. J., & Fantino, E. (2022) · Journal of Cellular Signaling · doi:10.33696/signaling.3.083 · Cited by 8
Mitochondrial Injury: A Hot Spot for Parkinsonism and Parkinson's Disease?
Giasson, B. I. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.48.pe42 · Cited by 8
Molecular Pathogenesis, Experimental Models and New Therapeutic Strategies for Parkinson‘s Disease
Yamashita, H., & Matsumoto, M. (2007) · Regenerative Medicine · doi:10.2217/17460751.2.4.447 · Cited by 8
Mitochondrial Pathology in Muscle of a Patient with a Novel Parkin Mutation
Hanagasi, H. A., Serdaroglu, P., Ozansoy, M., Basak, N. A., Tașlı, H., & Emre, M. (2009) · International Journal of Neuroscience · doi:10.1080/00207450903088019 · Cited by 8
Stress granules as a central hub linking organelle stress, aging, and neurodegeneration
Ham, H.-J., & Lee, J.-A. (2026) · BMB Reports · doi:10.5483/bmbrep.2025-0220 · Cited by 8
Mohabbat, M., & Arazi, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-58462-4 · Cited by 7
Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neuronsPreprint
Cronin, S. J. F., Yu, W., Hale, A., Licht‐Mayer, S., Crabtree, M. J., Korecka, J. A., Tretiakov, E. O., Sealey‐Cardona, M., Somlyay, M., Onji, M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.08.539795 · Cited by 7
Sharma, Y., Gupta, J. K., Babu, M. A., Singh, S., & Sindhu, R. K. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02269-5 · Cited by 7
Rango, M. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.05.007 · Cited by 7
Lee, D. H., Park, M. H., Hwang, C. J., Kim, Y., Hwang, D. Y., Han, S., & Hong, J. T. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0424-5 · Cited by 7
Current concepts on the etiology and pathogenesis of Parkinson disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00005-6 · Cited by 7
Kodsi, D. N. E., Tokarew, J. M., Sengupta, R., Lengacher, N. A., Ng, A. C., Boston, H., Jiang, Q., Palmberg, C., Pileggi, C. A., Shutinoski, B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.26.062380 · Cited by 7
Rybarski, M. O., Mrohs, D., Osenberg, K., Hemmersbach, M., Pfeffel, K., Steinkamp, J., Schmidt, D., Violou, K., Schäning, R., Schmidtke, K., et al. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15917 · Cited by 7
Eggers, B., Steinbach, S., Aldea, I. G., Keers, S. M., Molina, M., Grinberg, L. T., Heinsen, H., Leite, R. E. P., Attems, J., May, C., et al. (2025) · Advanced Biology · doi:10.1002/adbi.202400814 · Cited by 7
Khan, S. A., & Haider, M. F. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273323074241001071645 · Cited by 7
Neurodegeneration in Parkinson’s Disease: Genetics Enlightens Physiopathology
Corti, O., Fournier, M., & Brice, A. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_17 · Cited by 7
Alterations in Corticostriatal Synaptic Function in Huntington's and Parkinson's Diseases
Cepeda, C., Bamford, N. S., André, V. M., & Levine, M. S. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00035-4 · Cited by 6
Towards Small Molecules as Therapies for Alzheimer’s Disease and Other Neurodegenerative Disorders
Aziz, O., Bürli, R. W., Fischer, D. F., Frearson, J. A., & Wall, M. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-803959-5.50004-0 · Cited by 6
Mice Expressing Mutant Parkin Exhibit Hallmark Features of Parkinson's Disease
Hart, M. P., & Xu, A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1719-09.2009 · Cited by 6
Etiology and pathogenesis of Parkinson’s disease: role of mitochondrial pathology
Brini, M., Ottolini, & Calí, T. (2013) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s28413 · Cited by 6
Parkinson’s Disease and Parkin: Insights from Park2 Knockout Mice
Stephenson, S. E. M., Juliet, M., & Paul, J. (2012) · InTech eBooks · doi:10.5772/18148 · Cited by 6
Chiu, T., Huang, H., Chang, H., Wu, H.-R., & Wang, M.-J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032017 · Cited by 6
Animal Models of Parkinson's Disease to Aid Drug Discovery and Development
Merchant, K., Chesselet, M.-F., Hu, S., & Fahn, S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00017-5 · Cited by 6
Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse
Regoni, M., Zanetti, L., Comai, S., Mercatelli, D., Novello, S., Albanese, F., Croci, L., Consalez, G. G., Ciammola, A., Valtorta, F., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9050514 · Cited by 6
Trease, A. J., Totusek, S., Lichter, E. Z., Stauch, K. L., & Fox, H. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126441 · Cited by 5
Im, M., Klymenko, O. О., Gonchar, O. O., Karasevich, N. V., & In, K. (2023) · Neurophysiology · doi:10.1007/s11062-025-09958-w · Cited by 5
Mitochondrial Proteins in the Development of Parkinson’s Disease
Zilocchi, M., Fasano, M., & Alberio, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8367-0_2 · Cited by 5
Crif1 deficiency in dopamine neurons triggers early-onset parkinsonism
Heo, J. Y., Park, A. H., Lee, M. J., Ryu, M. J., Kim, Y. K., Jang, Y. S., Kim, S., Shin, S. Y., Son, H. J., Stein, T. D., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02234-5 · Cited by 5
Mitochondrial Degradation, Autophagy and Neurodegenerative Disease
Otten, E. G., Manni, D., & Korolchuk, V. I. (2016) · Springer eBooks · doi:10.1007/978-3-319-28637-2_11 · Cited by 5
Functional Role of Parkin against Oxidative Stress in Neural Cells
Hwang, M., Lee, J.-M., Kim, Y., & Geum, D. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.1.62 · Cited by 5
Metadata
- Authors
- Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Shen, Jie
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 279
- Issue
- 18
- Pages
- 18614-18622
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2140647923
- Cited by
- 995
- References
- 66
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 34 · 2023: 29 · 2022: 27 · 2021: 44 · 2020: 51 · 2019: 39 · 2018: 41 · 2017: 32 · 2016: 41 · 2015: 41 · 2014: 42 · 2013: 60 · 2012: 49
- FWCI
- 42.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6031 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- Parkin, Parkinson's disease, mitochondrial dysfunction, oxidative stress, E3 ubiquitin ligase, nigrostriatal pathway, complex I, cytochrome c oxidase, respiratory capacity, lipid peroxidation, protein peroxidation, serum antioxidant capacity, metabolic abnormalities
- MeSH terms
- Animals, Antioxidants, Basal Ganglia, Mitochondria, Oxidative Phosphorylation, Parkinson Disease, Protein Processing, Post-Translational, Weight Gain, Reactive Oxygen Species, Mice, Knockout, Oxidative Stress, Cell Respiration, Mitochondrial Proteins, Mitochondrial Diseases, Ubiquitin-Protein Ligases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.